Pfizer gains rights to Medivation Alzheimer's drug
|
|
|
| Posted
:
Wed, 03 Sep 2008 12:51:50 GMT |
| By
:
Reuters |
| Category
:
US (Business) |
| News Alerts by
Email ( click
here ) |
|
US Business News |
Home
|
|
|
|
NEW YORK (Reuters) - Pfizer Inc is acquiring rights to a promising experimental drug for Alzheimer's disease from Medivation Inc for as much as $725 million, sending Medivation shares up nearly 31 percent.Pfizer, which is seeking to boost its pipeline of experimental drugs, will pay an initial $225 million for rights to the medicine, Dimebon, which is also being developed for Huntington's disease, the companies said on Wednesday.The world's largest drug maker will pay San Francisco-based Medivation up to $500 million more should Dimebon reach various development and regulatory goals, plus additional undisclosed commercial milestone payments.Results for Dimebon were presented at a prominent Alzheimer's conference in July, when the drug showed it kept symptoms of the brain-wasting disease at bay for 18 months.No cure exists for Alzheimer's disease, the most common form of dementia, and current drugs just delay symptoms somewhat.Pfizer will collaborate on the Phase 3 program in Alzheimer's disease, Huntington's disease development, and regulatory filings in the United States.The New York-based company will assume 60 percent of U.S. development and commercialization expenses, and receive 60 percent of U.S. profits. Medivation will co-promote Dimebon to specialty physicians in the United States, should the drug reach the market.Pfizer will have responsibility for the drug outside the United States and will pay Medivation royalties on sales.Medivation started enrolling patients in June for a 525-patient Phase 3 trial for Alzheimer's disease.In July, Medivation said a mid-stage trial showed Dimebon significantly improved cognitive function in patients with Huntington's disease, a condition in which the degeneration of brain cells causes uncontrolled movement and loss of intellectual function.Medivation shares rose to $34 in premarket trading from Tuesday's close of $26.03. Pfizer rose 8 cents to $19.25.(Reporting by Lewis Krauskopf; Editing by Steve Orlofsky and Lisa Von Ahn)
(c) Reuters 2008. All rights reserved. Republication or redistribution of Reuters content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters and the Reuters sphere logo are registered trademarks and trademarks of the Reuters group of companies around the world.
|
|
|
|
|
|
Related News
FDIC: 'Problem' banks at 16-year high in US
Washington - The number of US banks in danger of collapse has risen to the highest level in 16 years, a government regulator reported Tuesday in a sign that the country's worst financial crisis in decades is still lingering. The Federal Deposit Insur...
American shoppers lace up racing shoes for Black Friday
Los Angeles - Up to 134 million Americans are expected to splash out with their cash when the holiday shopping season kicks off on traditional Black Friday. The National Retail Federation Tuesday said it anticipated that the easing recession will sen...
US stocks edge lower on revised growth figures
New York - US stocks fell slightly on Tuesday as government figures showed that last quarter's economic rebound was smaller than initially thought. The Commerce Department in an updated estimate said the economy grew at an annual rate of 2.8 per cent...
US economic rebound smaller than thought; Fed optimistic - Summary
Washington - The US economy's rebound from a deep recession was smaller than initially thought, according to new government figures Tuesday, while the Federal Reserve said it expects the country's recovery to pick up...
EXTRA: US central bank issues rosier outlook on economy
Washington - The Federal Reserve Tuesday raised its growth forecasts for the US economy, but warned that unemployment in the United States will remain for some time at its highest levels in a generation. The US central bank projected the world's larg...
US levies first-ever fines on airlines who stranded passengers
Washington - Three US airlines were fined a total of 175,000 dollars on Tuesday for leaving passengers stranded nearly six hours on an aircraft, the first-ever such penalty imposed by the US government. Continental Airlines and ExpressJet Airlines we...
US economy grew 2.8 per cent in third quarter - Summary
Washington - The US economy grew at an annual rate of 2.8 per cent in the third quarter of this year, according to an updated government estimate Tuesday that confirmed the United States has likely emerged from its deepest recession in decades. But t...
|
|
|
|
|
|
|
|
